Versant Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10K Buy
+2,155
New +$9.46K ﹤0.01% 2262
2026
Q2
– Sell
-200
Closed -$790 – 2815
2026
Q1
$790 Sell
200
-637
-76% -$3.21K ﹤0.01% 2681
2025
Q4
$5.67K Buy
837
+634
+312% +$4.44K ﹤0.01% 2209
2025
Q3
$1.42K Sell
203
-17
-8% -$118 ﹤0.01% 2466
2025
Q2
$1.34K Buy
220
+17
+8% +$113 ﹤0.01% 2450
2025
Q1
$1.54K Hold
203
– – ﹤0.01% 2308
2024
Q4
$1.95K Buy
+203
New +$1.58K ﹤0.01% 2066

Other funds holding MDXG

Versant Capital Management's MDXG Position: Q3 2026 in Review

Versant Capital Management opened a new position in MiMedx Group (MDXG) in Q3 2026: 2,155 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #2262 among its holdings. This is a return to the name: Versant Capital Management previously reported a position in MDXG as recently as Q1 2026.

Versant Capital Management first reported a position in MDXG in Q4 2024 and has held it in 7 quarters since. 98 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • Versant Capital Management held 2,155 shares of MiMedx Group worth $10K as of Q3 2026.
  • MiMedx Group was a new Versant Capital Management position in Q3 2026.
  • MiMedx Group made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2262 holding.
  • Versant Capital Management first reported a position in MiMedx Group in Q4 2024 and has held it in 7 quarters since.
  • 98 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.